order

partner

Cassava Sciences Inc

action

The day to day price action of this limp dick is more painful to watch than slugs breeding.

$SAVA , this daily one way action is depressing.

Zero confidence in management based on both recent actions and historical issues with the FDA. 2.

$SAVA We may get frustrated with volatility, manipulation, and irregular daily price action

price

This is sickening that these crooks can manipulate the price like this. !!!

He invites shorts to destroy stock price.. pathetic!

Some had to drop in price a little first!

new employee mr. cook must be pissed as this is lower price than the shares he got it for.

All.u did was dilute the pps 
..and release to prs to kill the stock price and momentum  
 You did so well..you fxuking scumbag.

I hate the stock price runup leading to an announcement.

data

- 
$AVXL in comparison, boring as hell - whenever Missling talks people fall asleep and holding back data and further readouts without any logical explanation are red flags -

$SAVA 
Pyggie here was bullish a few days ago, folded like a pussy because he can’t read data, and now spews FUD, like a spoiled child, because he’s worried he may have paper-handed a monster.

but offer only the “opinion” that there was “possible data manipulation.”

$SAVA longtime biotech investor and my honest experience when a CEO promises good data and there is a long waiting period = not good.

Sentiment matters in this game, and unfortunately, this company has been drug through the mud for so long that good data might just get overlooked.

$SAVA The ironic and sad thing is that this ticker has been abused and manipulated so badly that even if it triples on upcoming data release it still won&#39;t come close to ATH achieved on much less evidence of safety and efficacy.

The CEO belongs in jail with all this pump and dump stock manipulation and data manipulation

just annoying we all get so worked up and insulting when we, the retail investor, can neither move Remi to release data early or in truth, move the SP by buying or selling a few hundred shares.

$SAVA dumb management causing longs to lose confidence, you dont change the date of data release every few weeks, just give a date when you are certain and stick with that, its that simple

BIIB with a 27% chance of no decline - so bad, how can they even publish data like that.

patient

however, if you are a family member of Alz patient think about how fatiguing emotionally and financially it is to change diapers, have your name forgotten, or even have to take a license away from an otherwise healthy person.

but your day will come when you will pay back way more than the damage you have caused and the lives you have threatened from being treated for a debilitating disease.

$ALZN $ATHA $ORMP $SAVA $SPRC yes then go back to your scam board clown no need to trap others in this scam .. we know what value SAVA brings to their AD patients

Lecanemab approved - IV  infusion..increased infection risk, inconvenient for patients with MD&#39;s fully aware 
of side effects: brain swelling and bleeding. 2.

Eventually, the  
AD patient is unable to perform daily functions.

But the monoclonal antibody treatment also carries risks of brain swelling and bleeding.

$BIIB - lied and tried to push their bad drug Aduhelm on unsuspecting patients (one of which is a family member of mine).

3 deaths in 1900 trial patients.. how many deaths is our FDA going to inflict on millions of folks who are supposed to take this death drugs that also happen to have near-zero efficacy?? SMH

Avxl, not good they didn&#39;t have an agreement in place “plan for approval“ before they started the test fase 2b 500 patients.

$SAVA It&#39;s not only CRUEL for anyone to be prescribing any of these MABs for AD patients, it&#39;s impractical for both patients and the healthcare system in general.

application

$SAVA Words  to  to  ignorant,  never  hype  a  employee  from  fda,  shady  shiat! 🤡🤡🤡😂😂😂

It doesn&#39;t matter if drugs for terminal illnesses, have been approved after 6 months, because there is endless manipulation here, and this waiting game is based on either FDA approval or denial based on corruption at the agency?

This is such crap with the FDA my Father died a year ago from it

$BIIB $SAVA You would need uncommon patience to not be crazy mad at the system for this shenanigan approval process and decision from the FDA.

Idiots with no respect for integrity continues  to run 
wild within the FDA.

$SAVA once again we got fu*ked by the evil BIIB + FDA.

$SAVA THIS is how corrupt our FDA and state medical boards are.

$BIIB $SAVA  
I tell ya why - FDA is corrupt deep in its root, period!

$SAVA huge selling orders lined up 😳😳

$SAVA big selling orders lined up😳😳

$SAVA Here comes the yellow order that is music  to my eyes hahaha

$SAVA Steady large orders of accumulation

$SAVA Let’s not loose our momentum Buy Buy buy there a lot big orders this morning

$SAVA filled again looking forward to making million dollars next year on SAVA stock appreciation partnership or buyout
I love the sound of 2500 per share😍🎉💰

$SAVA the data could be so good that partnership or buyout on table

6- Positive results= case won 

Possible outcome before 2022 ends- Positive results, Winning short distort case, possible partner announcement, multiple halts, happy longs, and the most important thing….

$SAVA Partnership or buyout imminent great news coming 1.6 million bought shares data must be excellent extremely bullish

business-result

But the company actually has never seen before wonderful results.

And, make no mistake, the result are impressive.

It is the best results that have been seen in AD.

This could be huge in eliminating artificial FUD against the top-line results.

$SAVA Market is moving higher as SAVA is expecting data results.

Anavex is late like the sun comes up and still produces great results.

MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word &quot;Thrilled&quot; in Dec 6 PR.

Data tells me no safety issues, with a possible large therapeutic window.

Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated

$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.

but the data to date would predict continued efficacy that will be nigh on impossible to ignore.

$SAVA Institutional buying says data is good!! !

I’ll keep buying until data comes out…

Excited for the next data unveiling….bring it on!

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

This will bring in billions of revenue and it will make the life quality longer for AD patients.

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

CURING LEUKEMIA isn&#39;t a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

but mostly new hope for all the families and patients with AZ.

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

Vallon Pharmaceuticals Inc

float

We are essentially trading our float every 45 minutes!

$VLON this low float garbage 3 employees company y will die just like others once pump is done. 💩💩💩🗡🗡🗡🗡🗡

The float already kinda small so it will make it tiny.

$VLON float thin as fuck, fluffier news has ripped harder last week 😂💵💵💵🚀🚀🚀. .

drop

stop

suck

Fucking cocksuckers are going to kill another runner with there bull shit halts

trap

One huge buy order and $ASTI could be gone VERY quick!

news

however, will grow in the short term given the merger news

$LMFA and $VLON easy $2 run ..a ton of positive news

News due.. fueled for bullish move. ⏱⏱🧨🧨🧨

$VLON Will be nice to get some news AH then my investment will continue to yield high returns

Mid day top percent stock gainers on news and/or volume 
$VLON $WISH $OCUL $TOPS $COMS

$ACHV Love this easy up - I think good news soon.

$VLON Merger news makes it run stronger.🚀🤞

Top percent stock gainers into the open on news and/or volume 
$VLON $CLNN $COMS $TOPS $EBET

bull

They have the measure and formula for an easy 10-20x+ ESP once we went enter a new bull market.

$TRKA &amp; $VLON - getting ready for a bull run.

$VLON another 100 per cent tomorrow bulls ✅😇

We will see - lets hope for the best bulls!

$ASTI has me Some $PEGY vibes back to the Good old Bull run 2022

Some Bull Stocks getting started After a Shitty Last week like $VLON or $TOPS

Have Ticker ASTI on your WL

volume

👀👍🏼
$VLON consolidating at .70 loads of volume positive for up to $1 again
$BLPH gives good risk reward zone here, buy bottom consolidation  
$KA i only say positive things.

Looks like all volume and momentum is moving into ASTI !!

I just follow volume and trends from time to time so made a good play here

Volume increase gon push this to the highs

$VLON 12M more volume and we surpass Fridays volume!

MIND Technology Inc

Positive news on orders, JV partnership update, SEC compliance extension, or a host of other positive news could &quot;easily&quot; push the common&#39;s up $2 and set the course for strong recovery.

I like their vision and appreciate the decisions they make even s hard as it is to defer the Preferred payments they simply need to have capital to make these larger orders happen.

My guess is that we&#39;re looking at a much improved 2023 with higher stock prices, overall better results and bigger orders.

Finally Capps also mentioned the possibility for large orders in Q4 and all of this bodes well for the future of the company, so stay tuned for more information from MIND management.

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Mar, 9, 2023

Jan, 17, 2023

VLON

Vallon Pharmaceuticals Inc

49.05%

$0.28 - $0.41

Feb, 13, 2023

Feb, 13, 2023

MIND

MIND Technology Inc

-32.84%

$0.67 - $0.45

Jan, 25, 2023

Jan, 17, 2023

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Mar, 9, 2023

Jan, 17, 2023

Jan, 11, 2023

Dec, 9, 2022

Dec, 8, 2022

Dec, 2, 2022

Nov, 16, 2022

VLON

Vallon Pharmaceuticals Inc

49.05%

$0.28 - $0.41

Feb, 13, 2023

Feb, 13, 2023

MIND

MIND Technology Inc

-32.84%

$0.67 - $0.45

Jan, 25, 2023

Jan, 17, 2023

Dec, 30, 2022

Nov, 20, 2022